News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerus Corporation (CERS) Announces Contracts for 19 New INTERCEPT Blood System Illuminators in Russia


12/6/2011 7:09:34 AM

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that Russia’s Federal Medical-Biological Agency (FMBA) has awarded contracts for the purchase of 19 INTERCEPT Blood System illumination devices for blood centers throughout the country. Cerus will supply the INTERCEPT Illuminators through a Russian distributor.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES